TABLE OF CONTENTS
Volume 7, Issue 5 (October 2007)
In This Issue
In This Issue FREE
Pharmacogenomics J 7: 291-292; doi:10.1038/sj.tpj.6500479
EELS (Ethical, Economic, Legal & Social) Paper
Pharmacogenetics and ethical considerations: why care?
L Marx-Stölting
Pharmacogenomics J 7: 293-296; advance online publication, October 10, 2006; doi:10.1038/sj.tpj.6500425
Review
Molecular therapy in the microRNA era
T Wurdinger and F F Costa
Pharmacogenomics J 7: 297-304; advance online publication, December 26, 2006; doi:10.1038/sj.tpj.6500429
Original Articles
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism
A K Tiwari, S N Deshpande, B Lerer, V L Nimgaonkar and B K Thelma
Pharmacogenomics J 7: 305-311; advance online publication, September 12, 2006; doi:10.1038/sj.tpj.6500415
IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance
R L Roberts, R B Gearry, M L Barclay and M A Kennedy
Pharmacogenomics J 7: 312-317; advance online publication, October 17, 2006; doi:10.1038/sj.tpj.6500421
The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study
H Mulder, B Franke, A Aart van der – Beek van der, J Arends, F W Wilmink, A C G Egberts and H Scheffer
Pharmacogenomics J 7: 318-324; advance online publication, October 3, 2006; doi:10.1038/sj.tpj.6500422
Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens
M Dettling, I Cascorbi, C Opgen-Rhein and R Schaub
Pharmacogenomics J 7: 325-332; advance online publication, October 17, 2006; doi:10.1038/sj.tpj.6500423
Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations
A Zhang, Q Xing, S Qin, J Du, L Wang, L Yu, X Li, L Xu, M Xu, G Feng and L He
Pharmacogenomics J 7: 333-338; advance online publication, October 24, 2006; doi:10.1038/sj.tpj.6500424
Impact of 
2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy
D Badenhorst, G R Norton, K Sliwa, R Brooksbank, R Essop, P Sareli and A J Woodiwiss
Pharmacogenomics J 7: 339-345; advance online publication, November 21, 2006; doi:10.1038/sj.tpj.6500426
Diuretic–gene interaction and the risk of myocardial infarction and stroke
H Schelleman, O H Klungel, J C M Witteman, M M B Breteler, A Hofman, C M van Duijn, A de Boer and B H Ch Stricker
Pharmacogenomics J 7: 346-352; advance online publication, December 26, 2006; doi:10.1038/sj.tpj.6500428
Association of the mu-opioid receptor gene with smoking cessation
M R Munafò, K M Elliot, M F G Murphy, R T Walton and E C Johnstone
Pharmacogenomics J 7: 353-361; advance online publication, January 16, 2007; doi:10.1038/sj.tpj.6500432
